Title | Type | SJR | H index | Total Docs. (2021) | Total Docs. (3years) | Total Refs. (2021) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2021) | %Female (2021) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Annual Review of Cancer Biology | book series | 3.881 Q1 | 36 | 0 | 90 | 0 | 844 | 90 | 9.76 | 0.00 | 0.00 | |
2 | Vital and health statistics. Series 2, Data evaluation and methods research | book series | 5.541 Q1 | 33 | 4 | 12 | 78 | 89 | 12 | 7.20 | 19.50 | 61.90 | |
3 | Metal ions in life sciences | book series | 0.457 Q3 | 48 | 1 | 47 | 0 | 138 | 43 | 3.14 | 0.00 | 0.00 | |
4 | JIMD Reports | book series | 0.402 Q3 | 35 | 81 | 237 | 1979 | 446 | 117 | 1.85 | 24.43 | 54.06 | |
5 | Recent Results in Cancer Research | book series | 0.130 Q4 | 63 | 32 | 115 | 2650 | 376 | 1 | 1.67 | 82.81 | 0.00 | |
6 | International Review of Research in Developmental Disabilities | book series | 0.473 Q3 | 21 | 17 | 43 | 1421 | 60 | 27 | 1.29 | 83.59 | 0.00 | |
7 | EAI/Springer Innovations in Communication and Computing | book series | 0.178 Q4 | 26 | 455 | 804 | 11334 | 716 | 141 | 0.89 | 24.91 | 36.79 | |
8 | eMagRes | book series | 0.423 Q3 | 24 | 5 | 69 | 531 | 90 | 67 | 0.87 | 106.20 | 28.57 | |
9 | Frontiers in Clinical Drug Research - Alzheimer Disorders | book series | 0.248 Q3 | 3 | 0 | 7 | 0 | 4 | 1 | 0.57 | 0.00 | 0.00 | |
10 | Frontiers in Clinical Drug Research - Anti Infectives | book series | 0.359 Q3 | 2 | 13 | 14 | 1862 | 8 | 2 | 0.57 | 143.23 | 63.89 | |
11 | Frontiers in Diabetes | book series | 0.154 Q4 | 7 | 0 | 60 | 0 | 34 | 36 | 0.57 | 0.00 | 0.00 | |
12 | Advances in Anesthesia | book series | 0.224 Q3 | 11 | 16 | 45 | 1009 | 40 | 42 | 0.53 | 63.06 | 25.53 | |
13 | Anti-Obesity Drug Discovery and Development | book series | 1 | 5 | 2 | 1128 | 1 | 0 | 0.50 | 225.60 | 0.00 | ||
14 | RSC Detection Science | book series | 0.121 Q4 | 11 | 41 | 81 | 4443 | 36 | 6 | 0.43 | 108.37 | 0.00 | |
15 | Pediatric and Adolescent Medicine | book series | 0.109 Q4 | 7 | 0 | 17 | 0 | 7 | 16 | 0.41 | 0.00 | 0.00 | |
16 | Frontiers in Anti-infective Drug Discovery | book series | 0.157 Q4 | 3 | 6 | 9 | 772 | 3 | 8 | 0.33 | 128.67 | 0.00 | |
17 | New Developments in NMR | book series | 0.266 Q3 | 11 | 18 | 194 | 1566 | 105 | 17 | 0.31 | 87.00 | 0.00 | |
18 | NTP Technical Report on the Toxicity Studies Series | book series | 6 | 4 | 7 | 490 | 1 | 7 | 0.20 | 122.50 | 57.33 | ||
19 | Current Clinical Neurology | book series | 0.137 Q4 | 8 | 20 | 179 | 1702 | 29 | 21 | 0.15 | 85.10 | 0.00 | |
20 | Frontiers in Clinical Drug Research - Anti Allergy Agents | book series | 0.109 Q4 | 1 | 0 | 13 | 0 | 2 | 5 | 0.15 | 0.00 | 0.00 | |
21 | Advances in Alzheimer's Disease | book series | 0.101 Q4 | 10 | 1 | 73 | 190 | 1 | 39 | 0.01 | 190.00 | 25.00 | |
22 | Annual Review of Gerontology and Geriatrics | book series | 0.103 Q4 | 20 | 0 | 16 | 0 | 2 | 16 | 0.00 | 0.00 | 0.00 | |
23 | Current Problems in Dermatology | book series | 0.741 Q1 | 45 | 29 | 22 | 2095 | 98 | 21 | 0.00 | 72.24 | 32.65 | |
24 | Ecology and Control of Vector-Borne Diseases | book series | 6 | 13 | 20 | 929 | 16 | 0 | 0.00 | 71.46 | 18.60 | ||
25 | Frontiers in Clinical Drug Research - HIV | book series | 1 | 6 | 6 | 695 | 0 | 0 | 0.00 | 115.83 | 55.56 | ||
26 | Journal International de Bioethique | book series | 0.102 Q4 | 10 | 10 | 72 | 268 | 0 | 13 | 0.00 | 26.80 | 0.00 | |
27 | Masterclass in Neuroendocrinology | book series | 2 | 31 | 1 | 2289 | 0 | 1 | 0.00 | 73.84 | 0.00 | ||
28 | NTP Technical Report on the Toxicology and Carcinogenesis Studies Series | book series | 9 | 3 | 5 | 524 | 2 | 5 | 0.00 | 174.67 | 60.00 | ||
29 | Progress in Respiratory Research | book series | 0.128 Q4 | 8 | 0 | 24 | 0 | 10 | 20 | 0.00 | 0.00 | 0.00 | |
30 | Progress in Tumor Research | book series | 0.158 Q4 | 12 | 0 | 10 | 0 | 3 | 10 | 0.00 | 0.00 | 0.00 | |
31 | Recent Advances in Alzheimer Research | book series | 0.130 Q4 | 0 | 0 | 11 | 0 | 0 | 1 | 0.00 | 0.00 | 0.00 | |
32 | Receptors | book series | 0.280 Q3 | 11 | 23 | 44 | 1758 | 47 | 24 | 0.00 | 76.43 | 0.00 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®